title: Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation.
authors.forename: Amjad
authors.initials: A
authors.lastname: Hayat
authors.forename: Shaun R
authors.initials: SR
authors.lastname: McCann
authors.forename: Stephen
authors.initials: S
authors.lastname: Langabeer
authors.forename: Sandra
authors.initials: S
authors.lastname: Irvine
authors.forename: Mary Frances
authors.initials: MF
authors.lastname: McMullin
authors.forename: Eibhlin
authors.initials: E
authors.lastname: Conneally
mesh_terms: D000293:Adolescent; D000328:Adult; D001549:Benzamides; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate